AstraZeneca PLC, current enterprise value calculation

Current share price (P)	$64.57
No. shares of common stock outstanding	1,263,143,338
US$ in millions
Common equity (market value)¹	81,561)
Add: Non-controlling interests (per books)	19)
Total equity	81,580)
Add: Current interest-bearing loans and borrowings (per books)	2,446)
Add: Non-current interest-bearing loans and borrowings (per books)	8,397)
Total equity and debt	92,423)
Less: Other investments	795)
Less: Cash and cash equivalents	6,360)
Enterprise value (EV)	85,268)

¹ Common equity (market value) = Share price × No. shares of common stock outstanding
= 64.57 × 1,263,143,338

AstraZeneca PLC, EV calculation

	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Share price^1, 2	$64.57	$64.85	$49.62	$44.67	$49.90
No. shares of common stock outstanding¹	1,263,143,338	1,257,170,087	1,246,779,548	1,292,355,052	1,409,023,452
US$ in millions
Common equity (market value)³	81,561)	81,527)	61,865)	57,730)	70,310)
Add: Non-controlling interests (book value)	19)	29)	215)	226)	197)
Total equity	81,580)	81,556)	62,080)	57,956)	70,507)
Add: Current interest-bearing loans and borrowings (book value)	2,446)	1,788)	901)	1,990)	125)
Add: Non-current interest-bearing loans and borrowings (book value)	8,397)	8,588)	9,409)	7,338)	9,097)
Total equity and debt	92,423)	91,932)	72,390)	67,284)	79,729)
Less: Other investments	795)	796)	823)	4,248)	1,482)
Less: Cash and cash equivalents	6,360)	9,217)	7,701)	7,571)	11,068)
Enterprise value (EV)	85,268)	81,919)	63,866)	55,465)	67,179)

¹ Data adjusted for splits and stock dividends.

² Closing price as at the filing date of AstraZeneca PLC Annual Report.

³ 2014 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 64.57 × 1,263,143,338

Download chart

Item	Description	The company
EV	Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments.	AstraZeneca PLC EV increased from 2012 to 2013 and from 2013 to 2014.

AstraZeneca PLC (NYSE:AZN)

Enterprise Value (EV)